Advances in the immunopathogenesis of multiple sclerosis

Area of Science:

• Neuroimmunology
• Central Nervous System Disorders
• Autoimmune Diseases

Background:

• Multiple sclerosis (MS) is an inflammatory, demyelinating, and degenerative CNS disease.
• Immune dysregulation is increasingly recognized in MS pathogenesis.
• Environmental factors are implicated in MS development.

Purpose of the Study:

• To review current mechanisms of immune dysregulation in MS.
• To explore the impact of environmental risk factors on immunity in MS and its animal models.

Main Methods:

• Literature review of recent studies on MS pathogenesis.
• Analysis of immune cell involvement (innate and adaptive).
• Examination of environmental risk factors and their interaction with genetic predisposition.

Main Results:

• MS pathogenesis is heterogeneous, involving multiple immune cells beyond CD4 T-helper cells, including B cells, CD8 T cells, and microglia/macrophages.
• Pro-inflammatory CD4 Th1/Th17 subsets contribute, but other immune players are also significant.
• Environmental factors like Vitamin D deficiency, Epstein-Barr virus, smoking, diet, and microbiota interact with genetic risk factors to dysregulate immune responses in MS.

Conclusions:

• Understanding the complex immune mechanisms and environmental contributions is crucial for improving MS therapies.
• Targeting immune dysregulation and environmental triggers may offer new therapeutic avenues for MS.
• Further research into these interactions can help prevent disease progression.